Axim Biotechnologies, Inc.
AXIM
Revenue
17.48k
▼-35.50k▼-67.01%
3 Months ChangeAssets
3.73M
▼-206.92k▼-5.26%
3 Months ChangeLiabilities
13.26M
▲1.88M▲16.51%
3 Months ChangeFree Cash Flow
-255.35k
▼-255.35k-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-15
Form 8-K
ID: 0001096906-24-002002
2024-08-19
Form 10-Q
ID: 0001096906-24-001772
2024-05-20
Form 10-Q
ID: 0001096906-24-001202
2024-03-21
Form 8-K
ID: 0001096906-24-000539
2024-02-13
Form 8-K
ID: 0001096906-24-000199
2023-12-28
Form 8-K
ID: 0001096906-23-002456
2023-11-20
Form 10-Q
ID: 0001096906-23-002238
2023-08-21
Form 10-Q
ID: 0001096906-23-001655
2023-06-02
Form 8-K
ID: 0001096906-23-001228
2023-05-30
Form 8-K
ID: 0001096906-23-001206